doi.org/10.1016/j.bcp.2019.113771

AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo

..., Zhong Liu
47
Biochemical Pharmacology5.60
Volume: 172, Pages: 113771 - 113771
Published: Dec 18, 2019
Paper Fields
Paper Details
Title
AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo
DOI
doi.org/10.1016/j.bcp.2019.113771
Published Date
Dec 18, 2019
Journal
Biochemical Pharmacology
Volume
172
Pages
113771 - 113771
© 2026 Pluto Labs All rights reserved.